跳至产品信息
1 / 1

Bao H. Lab

Bao H. Lab Hair Loss Care Ampoulea

Bao H. Lab Hair Loss Care Ampoulea

常规价格 $95.00 SGD
常规价格 $109.00 SGD 促销价 $95.00 SGD
促销 售罄
结账时计算的运费
Size
Clinical Summary: Bao H. Lab Hair Loss Care Ampoule is a Korean-developed trichological cosmeceutical formulated with BEFF™ (Bacillus/Esculetin Ferment Filtrate) as the primary bioactive, delivered via a syringe-style ampoule applicator for targeted scalp infusion. BEFF™ penetrates the scalp to stimulate dermal papilla cell proliferation — the cells at the base of each hair follicle that govern hair fibre production. In comparative in vitro studies, BEFF™ demonstrated a greater than 10% higher growth rate of dermal papilla cells than minoxidil 2%, and a 125% increase in scalp density. The product is dermatologist-tested, free from parabens, sulfates, silicones, synthetic fragrances, and mineral oils, and is suitable for colour-treated hair and sensitive scalp conditions.

Product Overview

Bao H. Lab is a Korean trichology brand that has developed the BEFF™ biofermentation platform as a drug-free alternative to conventional minoxidil-based hair loss treatments. Hair loss (androgenetic alopecia, telogen effluvium, and stress-related alopecia) represents a significant clinical burden in Singapore's population, where thermal damage from humidity management, chemical processing, and nutritional factors contribute to high rates of diffuse hair thinning across both male and female demographics. The Hair Loss Care Ampoule delivers BEFF™ directly to the scalp via a precision applicator, ensuring targeted deposit of the bioactive in the perifolliculo-dermal region rather than distribution across the hair shaft, which has no follicular relevance.

BEFF™ contains Esculetin-enriched Bacillus ferment filtrate combined with camellia leaf and licorice root extracts, which exert synergistic anti-inflammatory, antioxidative, and sebum-regulating effects on the scalp microenvironment. Clinical and in vitro data published by the manufacturer indicate a 25% increase in scalp density within 2 weeks of regular use, and a 115% increase in the growth rate of follicle organoids (laboratory models that simulate hair length and thickness development). The formulation is positioned for use by healthcare professionals in trichology clinics and by individual consumers managing early-to-moderate hair thinning, particularly as a non-pharmacological first-line option or as an adjunct to nutritional and lifestyle interventions.

Specifications

Manufacturer Bao H. Lab (Republic of Korea)
Product Name Hair Loss Care Ampoule
Primary Bioactive BEFF™ — Bacillus/Esculetin Ferment Filtrate
Supporting Actives Camellia leaf extract (anti-inflammatory), licorice root extract (antioxidant, antioxidative), biotin complex
Mechanism of Action Dermal papilla cell proliferation stimulation; follicle organoid growth enhancement; scalp anti-inflammatory activity
Volume per Pack 2 ampoules × 12 ml (syringe-style applicator)
Applicator Precision syringe applicator for direct scalp delivery
Clinically Documented Outcome 25% increase in scalp density at 2 weeks; dermal papilla growth rate >10% above minoxidil 2%
Suitable Hair Types All hair types including colour-treated, chemically processed, and heat-styled hair
Formulation Profile Paraben-free, sulfate-free, silicone-free, synthetic fragrance-free, mineral oil-free; vegan formulation
Safety Testing Dermatologist-tested; suitable for sensitive scalp; no build-up or scalp irritation with long-term use
Regulatory Context Cosmeceutical classification (non-pharmaceutical); manufactured under Korean GMP standards aligned with ISO 22716:2007 (Cosmetics — Good Manufacturing Practices); notified to HSA Singapore under the ASEAN Cosmetic Directive (ACD) framework for legal cosmetic supply; Korean Ministry of Food and Drug Safety (MFDS/KFDA) cosmetic registration

Clinical Indications and Applications

  • Androgenetic alopecia (early to moderate): For patients with early-stage pattern hair loss seeking a drug-free, non-hormonal intervention that targets follicular health at the dermal papilla level without systemic side effects.
  • Telogen effluvium: Post-stress, post-partum, or post-illness diffuse hair shedding, where follicular stimulation and scalp anti-inflammation can support the transition of follicles from telogen back to anagen phase.
  • Adjunct to trichological treatments: Used alongside PRP (platelet-rich plasma), low-level laser therapy (LLLT), or scalp microneedling protocols in trichology clinic settings to enhance follicular response.
  • Sensitive or reactive scalp management: The anti-inflammatory properties of camellia and licorice extracts make this product suitable for patients whose hair loss is associated with scalp seborrhoea, folliculitis, or contact dermatitis.
  • Post-chemical or heat damage recovery: For patients experiencing thinning following repeated chemical processing, bleaching, or thermal styling, where follicular stress has contributed to premature telogen entry.

Frequently Asked Questions

Q: How does BEFF™ compare mechanistically to minoxidil for hair loss?
A: Minoxidil is a vasodilator that promotes hair growth primarily by extending the anagen (growth) phase of the hair cycle and increasing dermal papilla cell size. BEFF™ works via a distinct pathway — direct stimulation of dermal papilla cell proliferation and support of follicle organoid development. In comparative in vitro testing, BEFF™ achieved a dermal papilla growth rate more than 10% higher than minoxidil 2%, without the cardiovascular side effects, scalp irritation, or initial telogen shedding that some patients experience with topical minoxidil. The two approaches may also be used concomitantly under trichological supervision.

Q: How often should the Hair Loss Care Ampoule be applied, and how is the syringe applicator used?
A: The recommended frequency is once daily application to a clean, dry scalp. The precision syringe applicator is used to deposit the ampoule contents directly onto the scalp in targeted zones of thinning or follicular stress. After application, gently massage the scalp for 1–2 minutes to promote absorption into the perifolliculo-dermal tissue. Wash hands after use. One pack (2 ampoules × 12 ml) provides a 2–4 week supply depending on the extent of the scalp area being treated.

Q: Is the product suitable for women experiencing post-partum hair loss?
A: Yes. Post-partum telogen effluvium is one of the primary indications for trichological cosmeceuticals such as the Bao H. Lab ampoule. The drug-free, vegan formulation is free from systemic hormonal actives, making it appropriate for breastfeeding mothers seeking to address hair loss without pharmacological intervention. As with any trichological concern during the post-partum period, consultation with a dermatologist or GP is advised to exclude nutritional deficiencies (particularly iron, ferritin, and zinc) as co-contributing factors.

Q: Can Singapore trichology clinics procure this product for in-clinic use?
A: Yes. EMIS Asia supplies the Bao H. Lab Hair Loss Care Ampoule to trichology clinics, dermatology practices, and hair loss treatment centres across Singapore. Clinic pricing and multi-unit procurement are available through the EMIS Asia B2B channel. The product may also be retailed directly to patients as a take-home maintenance treatment between in-clinic sessions.

Q: How quickly can results be expected, and what is the recommended treatment duration?
A: Clinical data from the manufacturer indicate measurable scalp density improvements within 2 weeks of consistent daily use. More substantive hair thickness and growth rate improvements, consistent with a 115% increase in follicle organoid growth rate seen in preclinical testing, are typically observed at 4–8 weeks of regular use. Trichologists recommend a minimum 3-month treatment period to evaluate follicular response, as the anagen phase of the hair cycle spans 2–7 years and one complete hair cycle transition takes approximately 3–6 months to observe clinically.

查看完整详细信息